Evaluation of the Safety and Efficacy of Razuprotafib in Hospitalized Subjects With Coronavirus Disease 2019
Clinical trial NCT04511650 · TERMINATED
Trial details
- NCT number
- NCT04511650
- Sponsor
- EyePoint Pharmaceuticals, Inc.
- Status
- TERMINATED
- Phase
- Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2020-10-21
- Primary completion
- 2021-02-26
- Enrollment
- 31
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.